FMR CORP 13D/13G Filings for Aurinia Pharmaceuticals Inc. (AUPH)

FMR CORP 13D and 13G filings for Aurinia Pharmaceuticals Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-08
10:15 am
Sale
2021-02-05 13G Aurinia Pharmaceuticals Inc.
AUPH
FMR CORP 5,762,773
4.557%
-2,267,285decrease
(-28.23%)
Filing